Atherosclerotic Cardiovascular Disease

Healio and Cardiology Today have aggregated a list of the most-read news on racial disparities in CV health and care.

Race alone may not explain disparities in risk for atherosclerotic CVD among patients with familial hypercholesterolemia, according to data presented at the virtual National Lipid Association Scientific Sessions.

Type 2 diabetes agents with proven cardiovascular benefit may be useful for patients with type 1 diabetes to prevent atherosclerotic CVD, but more robust data are needed for the type 1 population, according to two speakers who debated the issue.

In new data from the THALES trial of patients with prior stroke, the benefit of ticagrelor plus aspirin for secondary stroke prevention was greatest in those with ipsilateral atherosclerotic stenosis.

Among patients with established atherosclerotic heart disease on dialysis, the effect of statins on CV events was modest at best, according to a study published in the American Heart Journal.

A new study highlights a significant cumulative increase in the rate of hospitalizations for atherosclerotic CVD in Black adults with diabetes.

The pooled cohort equations for atherosclerotic CVD prediction can be used as a risk-estimation tool for adults across BMI categories, but may overestimate ASCVD risk for individuals in overweight and obese categories.

An LPA genetic risk score with 43 single nucleotide variants provided similar risk prediction for atherosclerotic CVD compared with measuring lipoprotein(a), researchers found.

Over 2 decades, various research and analyses have indicated that although residual LDL and inflammation are both associated with CV risk, they should be targeted individually for optimal outcomes in secondary prevention, a speaker said.

Alerting cardiologists with active or passive prompts within electronic health records regarding statin therapy in eligible patients with atherosclerotic CVD did not significantly change prescribing rates, researchers found.